chr17-76471301-A-AC
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001005498.4(RHBDF2):c.*331dupG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0241 in 294,462 control chromosomes in the GnomAD database, including 463 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.040 ( 409 hom., cov: 33)
Exomes 𝑓: 0.0066 ( 54 hom. )
Consequence
RHBDF2
NM_001005498.4 3_prime_UTR
NM_001005498.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.07
Genes affected
RHBDF2 (HGNC:20788): (rhomboid 5 homolog 2) Predicted to enable protein transporter activity. Predicted to be involved in negative regulation of protein secretion and regulation of epidermal growth factor receptor signaling pathway. Located in plasma membrane. Implicated in palmoplantar keratoderma-esophageal carcinoma syndrome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 17-76471301-A-AC is Benign according to our data. Variant chr17-76471301-A-AC is described in ClinVar as [Benign]. Clinvar id is 325411.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.134 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHBDF2 | ENST00000675367 | c.*331dupG | 3_prime_UTR_variant | Exon 19 of 19 | NM_001005498.4 | ENSP00000501790.1 | ||||
RHBDF2 | ENST00000313080 | c.*331dupG | 3_prime_UTR_variant | Exon 19 of 19 | 1 | ENSP00000322775.3 | ||||
RHBDF2 | ENST00000590168.5 | n.2254dupG | non_coding_transcript_exon_variant | Exon 12 of 12 | 1 | |||||
RHBDF2 | ENST00000591885 | c.*331dupG | 3_prime_UTR_variant | Exon 19 of 19 | 5 | ENSP00000466867.1 |
Frequencies
GnomAD3 genomes AF: 0.0404 AC: 6146AN: 152094Hom.: 407 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
6146
AN:
152094
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00659 AC: 938AN: 142250Hom.: 54 Cov.: 0 AF XY: 0.00595 AC XY: 438AN XY: 73568 show subpopulations
GnomAD4 exome
AF:
AC:
938
AN:
142250
Hom.:
Cov.:
0
AF XY:
AC XY:
438
AN XY:
73568
Gnomad4 AFR exome
AF:
AC:
639
AN:
5052
Gnomad4 AMR exome
AF:
AC:
75
AN:
5568
Gnomad4 ASJ exome
AF:
AC:
19
AN:
4606
Gnomad4 EAS exome
AF:
AC:
0
AN:
9492
Gnomad4 SAS exome
AF:
AC:
3
AN:
12944
Gnomad4 FIN exome
AF:
AC:
1
AN:
6432
Gnomad4 NFE exome
AF:
AC:
71
AN:
89202
Gnomad4 Remaining exome
AF:
AC:
125
AN:
8324
Heterozygous variant carriers
0
42
84
127
169
211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0405 AC: 6161AN: 152212Hom.: 409 Cov.: 33 AF XY: 0.0391 AC XY: 2912AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
6161
AN:
152212
Hom.:
Cov.:
33
AF XY:
AC XY:
2912
AN XY:
74436
Gnomad4 AFR
AF:
AC:
0.136898
AN:
0.136898
Gnomad4 AMR
AF:
AC:
0.0204002
AN:
0.0204002
Gnomad4 ASJ
AF:
AC:
0.00317003
AN:
0.00317003
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000414938
AN:
0.000414938
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.00102923
AN:
0.00102923
Gnomad4 OTH
AF:
AC:
0.0397727
AN:
0.0397727
Heterozygous variant carriers
0
271
542
813
1084
1355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
36
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Palmoplantar keratoderma-esophageal carcinoma syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at